Conatus Pharmaceuticals' IPO

Conatus Pharmaceuticals raised a round of funding on July 25, 2013. Investors include Public.

Conatus Pharmaceuticals, a privately-held biotechnology company, is engaged in the development of human therapeutics to treat liver disease. Conatus is developing its lead compound, emricasan, for the…

Articles about Conatus Pharmaceuticals' IPO: